Bullous Dermatoses in Pregnancy

Research output: Contribution to journalReview article

Abstract

This paper reviews the clinics and therapy of some very rare constellations: autoimmune bullous diseases in pregnancy. In this context of the immunology of healthy pregnancy, the term of fetal-maternal tolerance and the consequences of the lost or damaged tolerance during early or late pregnancy will be briefly introduced. We will discuss the course of autoimmune blistering diseases during gravidity, their diagnosis, including differential from other gestational dermatoses and the possible fetal outcome. As the most common of the pregnancy-induced autoimmune blistering diseases, pemphigoid gestationis will be detailed, together with the significant development on fetal-maternal immunology and disease pathology. Management of patients with pemphigus and pemphigoid group of diseases as well as therapy, diet, and follow-up suggested for gravidas with dermatitis herpetiformis will be summarized. The current status and pregnancy safety categories of immunosuppressive and adjuvant treatment modalities will be highlighted.

Original languageEnglish
Pages (from-to)214-221
Number of pages8
JournalCurrent Dermatology Reports
Volume1
Issue number4
DOIs
Publication statusPublished - Jan 1 2012

Fingerprint

Vesiculobullous Skin Diseases
Pregnancy
Autoimmune Diseases
Allergy and Immunology
Pemphigoid Gestationis
Mothers
Gravidity
Dermatitis Herpetiformis
Diet Therapy
Bullous Pemphigoid
Pemphigus
Immunosuppressive Agents
Fetal Development
Skin Diseases
Differential Diagnosis
Pathology
Safety
Therapeutics

Keywords

  • Dermatitis herpetiformis
  • Fetal outcome
  • Pemphigoid
  • Pemphigoid gestationis
  • Pemphigus
  • Pregnancy

ASJC Scopus subject areas

  • Dermatology

Cite this

Bullous Dermatoses in Pregnancy. / Kárpáti, S.

In: Current Dermatology Reports, Vol. 1, No. 4, 01.01.2012, p. 214-221.

Research output: Contribution to journalReview article

@article{b6876ce1c0a3498a858a6a9d5ffb5d77,
title = "Bullous Dermatoses in Pregnancy",
abstract = "This paper reviews the clinics and therapy of some very rare constellations: autoimmune bullous diseases in pregnancy. In this context of the immunology of healthy pregnancy, the term of fetal-maternal tolerance and the consequences of the lost or damaged tolerance during early or late pregnancy will be briefly introduced. We will discuss the course of autoimmune blistering diseases during gravidity, their diagnosis, including differential from other gestational dermatoses and the possible fetal outcome. As the most common of the pregnancy-induced autoimmune blistering diseases, pemphigoid gestationis will be detailed, together with the significant development on fetal-maternal immunology and disease pathology. Management of patients with pemphigus and pemphigoid group of diseases as well as therapy, diet, and follow-up suggested for gravidas with dermatitis herpetiformis will be summarized. The current status and pregnancy safety categories of immunosuppressive and adjuvant treatment modalities will be highlighted.",
keywords = "Dermatitis herpetiformis, Fetal outcome, Pemphigoid, Pemphigoid gestationis, Pemphigus, Pregnancy",
author = "S. K{\'a}rp{\'a}ti",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/s13671-012-0029-3",
language = "English",
volume = "1",
pages = "214--221",
journal = "Current Dermatology Reports",
issn = "2162-4933",
publisher = "Springer US",
number = "4",

}

TY - JOUR

T1 - Bullous Dermatoses in Pregnancy

AU - Kárpáti, S.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - This paper reviews the clinics and therapy of some very rare constellations: autoimmune bullous diseases in pregnancy. In this context of the immunology of healthy pregnancy, the term of fetal-maternal tolerance and the consequences of the lost or damaged tolerance during early or late pregnancy will be briefly introduced. We will discuss the course of autoimmune blistering diseases during gravidity, their diagnosis, including differential from other gestational dermatoses and the possible fetal outcome. As the most common of the pregnancy-induced autoimmune blistering diseases, pemphigoid gestationis will be detailed, together with the significant development on fetal-maternal immunology and disease pathology. Management of patients with pemphigus and pemphigoid group of diseases as well as therapy, diet, and follow-up suggested for gravidas with dermatitis herpetiformis will be summarized. The current status and pregnancy safety categories of immunosuppressive and adjuvant treatment modalities will be highlighted.

AB - This paper reviews the clinics and therapy of some very rare constellations: autoimmune bullous diseases in pregnancy. In this context of the immunology of healthy pregnancy, the term of fetal-maternal tolerance and the consequences of the lost or damaged tolerance during early or late pregnancy will be briefly introduced. We will discuss the course of autoimmune blistering diseases during gravidity, their diagnosis, including differential from other gestational dermatoses and the possible fetal outcome. As the most common of the pregnancy-induced autoimmune blistering diseases, pemphigoid gestationis will be detailed, together with the significant development on fetal-maternal immunology and disease pathology. Management of patients with pemphigus and pemphigoid group of diseases as well as therapy, diet, and follow-up suggested for gravidas with dermatitis herpetiformis will be summarized. The current status and pregnancy safety categories of immunosuppressive and adjuvant treatment modalities will be highlighted.

KW - Dermatitis herpetiformis

KW - Fetal outcome

KW - Pemphigoid

KW - Pemphigoid gestationis

KW - Pemphigus

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85069329045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069329045&partnerID=8YFLogxK

U2 - 10.1007/s13671-012-0029-3

DO - 10.1007/s13671-012-0029-3

M3 - Review article

AN - SCOPUS:85069329045

VL - 1

SP - 214

EP - 221

JO - Current Dermatology Reports

JF - Current Dermatology Reports

SN - 2162-4933

IS - 4

ER -